Table 1.

Guideline manuscript template conformation to reporting checklists

DomainGIN-McMaster checklist (step)RIGHT (topic)AGREE II (item)Guideline manuscript template (page)*
Basic information     
 Title — — 
 Authors 15.3 — — 
 Abstract — — — 
 Executive summary — 17 
 Abbreviations and acronyms — — 
 Corresponding developer — — 
Background     
 Brief description of the health problem 2.9 — 
 Aims of the guideline and specific objectives 2.2 
 Target populations 8.3, 8.7 2 & 3 
 End users and settings 
 Guideline development groups 
Evidence     
 Health care questions 10 
 Systematic reviews 10, 11 11 7, 8 
 Assessment of the certainty of the body of evidence 12 12 10 
Recommendations     
 Recommendations 13 & 14 13 10, 11, 15, 16, 20 13 
 Rationale for recommendations 13.6 14 5, 12, 20 13 
 Evidence to decision process 13.1 15 10, 12 
Review and quality assurance     
 External review 15.7, 15.8 16 13 12 
 Quality assurance 15.6 17 — 12 
Funding and declaration and management of interests     
 Funding sources and roles of the funder 7.6 18 22 
 Declaration and management of interests 19 23 
Other information     
 Access 16.1 20 — Whole document (eg, citation to guideline, links to EtDs with evidence profiles, and supplements) 
 Suggestions for further research 13.5 21 — Each recommendation (EtD) 
 Limitations of the guideline — 22 — 15 
 Updating the guideline 18 — 14 16 
 Applicability 14.5 14 14 Whole document (eg, feasibility, barriers for each recommendation) 
 Implementation 16 — 18, 19 Each recommendation (EtD) & 16 (local adaptation) 
 Monitoring 17.3 — 21 Each recommendation (EtD) 
DomainGIN-McMaster checklist (step)RIGHT (topic)AGREE II (item)Guideline manuscript template (page)*
Basic information     
 Title — — 
 Authors 15.3 — — 
 Abstract — — — 
 Executive summary — 17 
 Abbreviations and acronyms — — 
 Corresponding developer — — 
Background     
 Brief description of the health problem 2.9 — 
 Aims of the guideline and specific objectives 2.2 
 Target populations 8.3, 8.7 2 & 3 
 End users and settings 
 Guideline development groups 
Evidence     
 Health care questions 10 
 Systematic reviews 10, 11 11 7, 8 
 Assessment of the certainty of the body of evidence 12 12 10 
Recommendations     
 Recommendations 13 & 14 13 10, 11, 15, 16, 20 13 
 Rationale for recommendations 13.6 14 5, 12, 20 13 
 Evidence to decision process 13.1 15 10, 12 
Review and quality assurance     
 External review 15.7, 15.8 16 13 12 
 Quality assurance 15.6 17 — 12 
Funding and declaration and management of interests     
 Funding sources and roles of the funder 7.6 18 22 
 Declaration and management of interests 19 23 
Other information     
 Access 16.1 20 — Whole document (eg, citation to guideline, links to EtDs with evidence profiles, and supplements) 
 Suggestions for further research 13.5 21 — Each recommendation (EtD) 
 Limitations of the guideline — 22 — 15 
 Updating the guideline 18 — 14 16 
 Applicability 14.5 14 14 Whole document (eg, feasibility, barriers for each recommendation) 
 Implementation 16 — 18, 19 Each recommendation (EtD) & 16 (local adaptation) 
 Monitoring 17.3 — 21 Each recommendation (EtD) 
*

Supplement 1; —, not addressed.

or Create an Account

Close Modal
Close Modal